Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

The even rarer sarcomas: Treating the untreatable

Clinical trials for the ultra-rare cancers: The regulator’s perspective

Date

28 Sep 2019

Session

The even rarer sarcomas: Treating the untreatable

Topics

Clinical Research;  Targeted Therapy;  Translational Research

Tumour Site

Sarcoma

Presenters

Ralf Herold

Authors

R. Herold

Author affiliations

  • Oncology, Haematology And Diagnostics, European Medicines Agency - Amsterdam, 1083 HN - Amsterdam/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Conclusions and perspectives

Presenter: Maud Toulmonde

Session: The even rarer sarcomas: Treating the untreatable

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.